SLC5A2 and congenital rubella syndrome: Also, other therapeutic options include some antidiabetic drugs, for example, sodium-glucose cotransporter 2 (SGLT2) inhibitors, dapagliflozin, and canagliflozin that have been shown highly effective in CRS [72, 75–78].